Market Place
Sourcing Support
Publication relating to transparency notifications
27 Feb 2026 //
GLOBENEWSWIRE
Total Voting Rights and Shares Information
25 Feb 2026 //
GLOBENEWSWIRE
Nyxoah Signs MOU with Sheikh Shakhbout Hospital
18 Feb 2026 //
GLOBENEWSWIRE
Nyxoah Expands Belgian Manufacturing Capacity For Global Growth
21 Jan 2026 //
GLOBENEWSWIRE
Nyxoah Reports Q4 & FY 2025 Results; Q1 2026 Revenue Guidance
12 Jan 2026 //
GLOBENEWSWIRE
Nyxoah To Present At J.P. Morgan Healthcare Conference
29 Dec 2025 //
GLOBENEWSWIRE
Nyxoah Announces Issuance Of First Tranche Of Convertible Bonds
19 Dec 2025 //
GLOBENEWSWIRE
Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy
17 Dec 2025 //
GLOBENEWSWIRE
Publication of Transparency Notifications
02 Dec 2025 //
GLOBENEWSWIRE
Nyxoah Joins Piper Sandler Healthcare Conference
27 Nov 2025 //
GLOBENEWSWIRE
Nyxoah`s Genio Therapy Sees Major 2026 Medicare Reimbursement
26 Nov 2025 //
GLOBENEWSWIRE
Total Voting Rights and Shares Update
20 Nov 2025 //
GLOBENEWSWIRE
Nyxoah Secures Up to $77M to Advance U.S. Genio Launch
13 Nov 2025 //
GLOBENEWSWIRE
Nyxoah Reports Third Quarter 2025 Financial And Operating Results
13 Nov 2025 //
GLOBENEWSWIRE
Nyxoah To Participate In The Stifel 2025 Healthcare Conference
03 Nov 2025 //
GLOBENEWSWIRE
Nyxoah To Unveil Q3 2025 Financial Results On Nov 13
30 Oct 2025 //
GLOBENEWSWIRE
Nyxoah Implants First U.S. Patients With Genio System
06 Oct 2025 //
GLOBENEWSWIRE
Publication Relating To Transparency Notifications
03 Oct 2025 //
GLOBENEWSWIRE
Nyxoah Updates on Expanded Middle East Presence
23 Sep 2025 //
GLOBENEWSWIRE
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical
15 Sep 2025 //
GLOBENEWSWIRE
Publication Relating to Transparency Notifications
05 Sep 2025 //
GLOBENEWSWIRE
Nyxoah Reveals Future Investor Events
02 Sep 2025 //
GLOBENEWSWIRE
Information on the total number of voting rights and shares
29 Aug 2025 //
GLOBENEWSWIRE
Nyxoah Reports Second Quarter Financial and Operating Results
18 Aug 2025 //
GLOBENEWSWIRE
Nyxoah Plans US Debut of OSA Implant Amid Rival`s Patent Suit
13 Aug 2025 //
FIERCE BIOTECH
Nyxoah Reveals Preliminary Q2 2025 Results
11 Aug 2025 //
GLOBENEWSWIRE
FDA Approves Nyxoah`s Genio® System for Sleep Apnea Treatment
08 Aug 2025 //
GLOBENEWSWIRE
Nyxoah`s Q2 2025 Financial Results to be Released on August 18
29 Jul 2025 //
GLOBENEWSWIRE
Total Number of Voting Rights and Shares Info
29 Jul 2025 //
GLOBENEWSWIRE
Nyxoah`s DREAM Study Data Featured in Clinical Sleep Journal
28 Jul 2025 //
GLOBENEWSWIRE
Information on The Total Number of Voting Rights and Shares
27 Jun 2025 //
GLOBENEWSWIRE
Company`s extraordinary shareholders` meeting on July 2, 2025
13 Jun 2025 //
GLOBENEWSWIRE
Publication Relating to Transparency Notifications
30 May 2025 //
GLOBENEWSWIRE
Nyxoah to Present at the Jefferies Global Healthcare Conference
28 May 2025 //
GLOBENEWSWIRE
Information on Total Number of Voting Rights and Shares
23 May 2025 //
GLOBENEWSWIRE
Nyxoah Reports First Quarter Financial and Operating Results
14 May 2025 //
GLOBENEWSWIRE
Annual and extraordinary shareholders` meetings on June 11, 2025
09 May 2025 //
GLOBENEWSWIRE
Publication relating to transparency notifications
09 May 2025 //
GLOBENEWSWIRE
Nyxoah to Release Q1 2025 Financial Results on May 14, 2025
07 May 2025 //
GLOBENEWSWIRE
Conditional Issuance of Shares
16 Apr 2025 //
GLOBENEWSWIRE
Nyxoah Provides Update on FDA Approvable Letter for Genio System
08 Apr 2025 //
GLOBENEWSWIRE
FDA Issues Nyxoah an Approvable Letter for its Genio® System
26 Mar 2025 //
GLOBENEWSWIRE
Nyxoah Reports 2024 Financial and Operating Results
13 Mar 2025 //
GLOBENEWSWIRE
Nyxoah to Release Q4 and FY 2024 Financial Results on March 13
10 Mar 2025 //
GLOBENEWSWIRE
Nyxoah To Join Oppenheimer 35th Annual Healthcare MedTech Conf
03 Mar 2025 //
GLOBENEWSWIRE
Nyxoah Launches Genio Breakthrough Therapy In Middle East
19 Feb 2025 //
GLOBENEWSWIRE
Publication relating to transparency notifications
20 Jan 2025 //
GLOBENEWSWIRE
Publication relating to transparency notifications
20 Dec 2024 //
GLOBENEWSWIRE
Nyxoah Launches Genio® Innovative Therapy in England
12 Dec 2024 //
GLOBENEWSWIRE
Information on the total number of voting rights and shares
27 Nov 2024 //
GLOBENEWSWIRE
Nyxoah To Participate In Piper Sandler 36th Healthcare Conference
20 Nov 2024 //
GLOBENEWSWIRE
Shareholders` Meeting Invitation for Dec 19, 2024
19 Nov 2024 //
GLOBENEWSWIRE
Publication relating to transparency notifications
18 Nov 2024 //
GLOBENEWSWIRE
Nyxoah Reports Q3 Financial and Operating Results
06 Nov 2024 //
GLOBENEWSWIRE
Nyxoah Appoints John Landry as Chief Financial Officer
04 Nov 2024 //
GLOBENEWSWIRE
Publication relating to transparency notifications
25 Oct 2024 //
GLOBENEWSWIRE
Nyxoah To Release Q3 2024 Financial Results On Nov 6
22 Oct 2024 //
GLOBENEWSWIRE
Publication relating to transparency notifications
15 Oct 2024 //
GLOBENEWSWIRE
Publication relating to transparency notifications
09 Oct 2024 //
GLOBENEWSWIRE
Information on the total number of voting rights and shares
09 Oct 2024 //
GLOBENEWSWIRE
